Long-Term Safety and Efficacy of Donepezil in Patients with Dementia with Lewy Bodies: Results from a 52-Week, Open-Label, Multicenter Extension Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 36, Iss. 3-4, 2013-08 ,pp. : 229-241

Karger

Access to resources Recommend Favorite

Pretreatment Cognitive Profile Likely to Benefit from Donepezil Treatment in Dementia with Lewy Bodies: Pooled Analyses of Two Randomized Controlled Trials

By  

Dementia and Geriatric Cognitive Disorders, Vol. 42, Iss. 1-2, 2016-08 ,pp. : 58-68

Karger

Access to resources Recommend Favorite

Long-Term Safety and Efficacy of Donepezil in Patients with Severe Alzheimer’s Disease: Results from a 52-Week, Open-Label, Multicenter, Extension Study in Japan

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 3, 2009-02 ,pp. : 232-239

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Galantamine in Patients with Dementia with Lewy Bodies: A 24-Week Open-Label Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 6, 2007-04 ,pp. : 401-405

Karger

Access to resources Recommend Favorite

An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia

By Ohta Hiroyoshi   Oka Hiroshi   Usui Chie   Ohkura Masayuki   Suzuki Makoto   Nishioka Kusuki  

Modern Rheumatology, Vol. 23, Iss. 6, 2013-11 ,pp. : 1108-1115

Springer Publishing Company

Access to resources Recommend Favorite